Bank of America’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-162,900
Closed -$12.2M – 7733
2025
Q3
$12.2M Hold
162,900
– – ﹤0.01% 3097
2025
Q2
$12.1M Sell
162,900
-181,500
-53% -$12.6M ﹤0.01% 3056
2025
Q1
$27.8M Buy
344,400
+228,800
+198% +$19.7M ﹤0.01% 2122
2024
Q4
$9.04M Sell
115,600
-120,100
-51% -$10.2M ﹤0.01% 3055
2024
Q3
$22.1M Buy
235,700
+17,900
+8% +$1.5M ﹤0.01% 2307
2024
Q2
$17M Buy
217,800
+68,000
+45% +$5.55M ﹤0.01% 2412
2024
Q1
$13.6M Buy
149,800
+97,400
+186% +$8.1M ﹤0.01% 2656
2023
Q4
$4.05M Hold
52,400
– – ﹤0.01% 3729
2023
Q3
$3.57M Hold
52,400
– – ﹤0.01% 3719
2023
Q2
$4.26M Buy
+52,400
New +$4.18M ﹤0.01% 3561

Other funds holding GEHC

Bank of America's GEHC Position: Q2 2026 in Review

Bank of America reduced its GE HealthCare (GEHC) stake by 21% in Q2 2026, selling an estimated $58M and leaving 3,249,771 shares worth $208M. The position accounts for 0.01% of the portfolio, ranked #770.

Bank of America first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $392M in Q3 2025. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Bank of America held 3,249,771 shares of GE HealthCare worth $208M as of Q2 2026.
  • Bank of America sold 882,969 GE HealthCare shares in Q2 2026, an estimated $58M.
  • GE HealthCare made up 0.01% of Bank of America's portfolio in Q2 2026, its #770 holding.
  • Bank of America first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Bank of America's GE HealthCare position peaked at $392M in Q3 2025.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.